Renal-Hepatic-Pancreatic Dysplasia Type 2: Perinatal Lethal Condition or a Multisystemic Disorder with Variable Expressivity

Authors

Kathryn Gunther
Essam M Imseis
Joyce P Samuel
Elizabeth A Hillman
Tiina H Ojala
Timo Jahnukainen
Paul R Hillman

Publication Date

4-1-2023

Journal

Molecular Genetics and Genomics Medicine

Abstract

BACKGROUND: Renal-hepatic-pancreatic dysplasia type 2 (RHPD2) is a rare condition that has been described in the literature disproportionately in perinatal losses. The main features of liver and kidney involvement are well described, with cardiac malformations and cardiomyopathy adding additional variation to the phenotype. Many patients reported are within larger cohorts of congenital anomalies of kidney and urinary tract (CAKUT) or liver failure, and with minimal phenotypic and clinical course data.

METHODS: An independent series of phenotypes and prognosis was aggregated from the literature. In this literature review, we describe an additional patient with RHPD2, provide a clinical update on the oldest known living patient, and report the cumulative phenotypes from the existing published patients.

RESULTS: With now examining the 17 known patients in the literature, 13 died within the perinatal period-pregnancy to one year of life. Of the four cases living past the first year of life, one case died at 5 years secondary to renal failure, the other at 30 months secondary to liver and kidney failure. Two are currently alive and well at one year and 13 years. Two cases have had transplantation with one resulting in long-term survival.

CONCLUSIONS: These patients serve to expand the existing phenotype of RHPD2 as a perinatal lethal condition into a pediatric disorder with variable expressivity. Additionally, we introduce the consideration of transplantation and outcomes within this cohort and future patients.

Keywords

NEK8, renal‐hepatic‐pancreatic dysplasia type 2

Comments

PMID: 36756677